Market News
Stay updated with the latest market trends, earnings, and economic indicators.
From Woofs To Words: Chinese AI Pet Translator Claims 95% Accuracy; But There's A Catch
Meng Xiaoyi opened the window for pre-orders on May 1 ahead of its official retail launch and has garnered 10,000 reservations from international consumers.
Shadowfax eyes 30% growth in FY27, bets big on dark stores, Qcommerce push
The logistics startup plans to increase its dark store count to 100 from 15 currently in FY27 as it scales what it describes as "vertical quick commerce" category-focused hyperlocal delivery platforms spanning segments such as grocery, apparel, pet care and industrial supplies.
Central Garden & Pet Company stock hits 52-week high at $41.53 - Investing.com India
Central Garden & Pet Company stock hits 52-week high at $41.53Investing.com India
Central Garden & Pet Company A stock hits 52-week high at $37.71 - Investing.com India
Central Garden & Pet Company A stock hits 52-week high at $37.71Investing.com India
Plastic Packaging For Water, Sugar: Nothing Wrong In Displaying Warning, Says SC
The top court was hearing a plea filed by the PET Packaging Association for Clean Environment, challenging a February 2026 order of the Madras High Court.
Nirmal Bang sees defence growth, flags cement margin pressure on fuel costs
Jyoti Gupta, Senior Research Analyst at Nirmal Bang Institutional Equities, remains positive on defence, citing strong order books and execution visibility despite rich valuations, with picks like HAL and BEL. On cement, she sees limited gas impact but rising pet coke and coal costs may pressure margins. Demand may moderate, though she prefers large caps like Ambuja and UltraTech while staying cautious on weaker regional players.
Viyash Scientific acquires Italy’s BioForLife in Rs 188-crore European pet-care push
Under the agreement, Viyash will pay EUR 16.975 million (Rs.188 crore) for the acquisition, including deferred consideration, with the transaction expected to close within three months subject to regulatory approvals, the company said in a statement to stock exchanges.